The Frugl evolution
With a combination of highly detailed collected information and artificial intelligence, Frugl is offering consumers even deeper insight.
With a combination of highly detailed collected information and artificial intelligence, Frugl is offering consumers even deeper insight.
Many travellers can’t find an approved preventive medication, but Immuron is conducting a phase 2 clinical study to combat traveler’s diarrhea.
There is anticipation mixed with nervousness, but after a decade’s work, Argenica is at the point of delivering ARG-007 to patients.
A disturbing number of foreign satellites are cozying up to Western operations and one Sydney-based startup is finding out why.
Initial studies confirm 100 per cent success in producing processable signals using a novel and advanced AI-powered imagining technique.
With massive potential for a lithium-ion disruptor in hand, investors are paying attention to Altech and its surge towards market.
With plans locked on two high-tech battery facilities in Germany, Altech has secured the heavy investor backing to bring its ambitions to market.
The transformation of Twitter could be the beginnings of a financial super-app, but X comes fraught with unique challenges.
Well-funded and expanding, Frugl elevate a health tech entrepreneur with a proven track record to deliver its innovation to a fast-growing market.